Grainout Tablets

Grainout Tablets combine Propranolol Hydrochloride Sustained Release (40 mg) and Flunarizine Dihydrochloride (10 mg) in a single prescription formulation. This dual-action therapy is commonly prescribed for the preventive management of migraine headaches and is designed to help reduce the frequency, severity, and recurrence of migraine attacks. Manufactured under stringent pharmaceutical quality standards, Grainout Tablets are supplied in 10×10 Alu-Alu blister packs and are intended for use only under the supervision of a registered healthcare professional.

Category:

Grainout Tablets

Grainout Tablets are a prescription combination medicine containing Propranolol Hydrochloride (Sustained Release) 40 mg and Flunarizine Dihydrochloride 10 mg. The combination is widely prescribed for the prophylactic (preventive) treatment of migraine, helping reduce the frequency and intensity of migraine episodes in patients requiring long-term management.

The sustained-release formulation of Propranolol provides prolonged therapeutic action, while Flunarizine contributes to migraine prevention through its calcium channel blocking activity. Together, these ingredients offer a comprehensive approach to migraine prophylaxis under physician supervision.

Manufactured in compliance with stringent pharmaceutical quality standards, Grainout Tablets are available in a 10×10 Alu-Alu blister pack, ensuring product stability, convenience, and patient safety.

⭐ Key Benefits

✔ Helps reduce the frequency of migraine attacks

✔ Assists in lowering the severity of migraine episodes

✔ Supports long-term migraine prevention

✔ Sustained-release formulation for prolonged therapeutic effect

✔ Dual-action combination therapy

✔ High-quality pharmaceutical manufacturing

✔ Convenient Alu-Alu blister packaging

💊 Composition

Each uncoated bilayer tablet contains:

Propranolol Hydrochloride IP (Sustained Release) – 40 mg
Flunarizine Dihydrochloride IP – 10 mg
Approved Pharmaceutical Excipients
Colour: Yellow Oxide of Iron
🎯 Indications

Grainout Tablets may be prescribed for:

Prevention of migraine headaches
Long-term migraine prophylaxis
Reduction in migraine frequency
Reduction in migraine severity
Physician-directed neurological therapy

Use only as directed by a registered medical practitioner.

✨ Product Highlights
Dual-action migraine preventive therapy
Sustained Release (SR) formulation
Propranolol + Flunarizine combination
High pharmaceutical quality
Prescription medicine
Easy-to-swallow tablets
Stable Alu-Alu blister packaging
⚙️ How It Works
Propranolol Hydrochloride (SR) is a beta-blocker that helps reduce migraine frequency by stabilizing vascular and neurological activity.
Flunarizine Dihydrochloride is a selective calcium channel blocker that helps prevent migraine attacks by reducing abnormal calcium influx into nerve cells and improving cerebral vascular stability.

Together, these medicines provide effective preventive management of migraine under physician supervision.

💉 Dosage & Administration
Take only as prescribed by your physician.
Swallow the tablet whole with water.
Do not crush or chew sustained-release tablets.
Follow the dosage schedule recommended by your healthcare professional.
⚠️ Safety Information
Prescription medicine.
Do not self-medicate.
Take only under medical supervision.
Keep out of reach of children.
Read the package insert carefully before use.
Do not exceed the prescribed dosage.
📦 Storage
Store in a cool and dry place.
Protect from moisture and direct sunlight.
Store below the recommended temperature.
Keep tablets in the original blister until use.

Scroll to Top